| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.24 | 1e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |